- When CEO Deven McGlenn of NeoClone
secured equity money early this year to grow his life science company, he made a commitment to his investors to take a more aggressive approach to marketing.
In the past, NeoClone, a seven-year-old manufacturer of monoclonal antibodies, has grown its revenues and built a customer base organica......Full article >>>
"My proposal was to build an industry-first, end-to-end solution from basic science to clinical trials," said Haroon, general manager and global vice president, VWR Biosciences.
VWR BioSciences is a service provider for its clients, while simultaneously acting as a marketing agent for contract research organizations (CROs) like NeoClone.
"It's an organization which represents......Full article >>>
w outdated, early-stage, low-cost provider image.
Representatives earn an additional premium for each sale that is $1,000 over the contract price that NeoClone sets. A larger sale means larger royalties for VWR BioSciences and a better reputation for NeoClone.
"My goal is to pay more on commission," McGlenn said.
To assuage potenti......Full article >>>
Source:wistechnology.com By Chris Fleissner 07/17/06Related biology technology :1
. Jellyfish partners for sales tracking technology2
. Doyle wants sales tax applied to digital downloads3
. Mortgagebot builds online sales even as housing declines4
. Third Wave reports another loss, stronger sales5
. Johnson Controls reports record quarterly sales6
. Sonic Foundry reports quarterly loss, higher Mediasite sales7
. My-oh, its BIO! Where sales hype and science collide8
. Third Wave shuffles finance, sales management9
. Johnson Controls sales up, profits down10
. Turning ads into sales: Context is king11
. Criticare reports 20.3 percent increase in sales